• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期药物流产行手术干预的危险因素。

Risk factors for surgical intervention of early medical abortion.

机构信息

Department of Gynaecology, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Institute of Statistics, Ulm University, Ulm, Germany.

出版信息

Am J Obstet Gynecol. 2019 May;220(5):478.e1-478.e15. doi: 10.1016/j.ajog.2019.02.014. Epub 2019 Feb 11.

DOI:10.1016/j.ajog.2019.02.014
PMID:30763542
Abstract

BACKGROUND

By being noninvasive, medical termination of pregnancy has increased worldwide access to abortion and improved safety of unsafe abortion. However, secondary surgical intervention is the most frequent complication to medical abortion.

OBJECTIVE

We aimed to identify and quantify risk factors for surgical intervention in women undergoing medically induced termination of pregnancy before 9 completed weeks of gestation.

STUDY DESIGN

We conducted a nationwide cohort study, including all pregnancies terminated before 63 gestational days in women aged 15-49 years during the period 2005-2015. Induction regimen was 200 mg mifepristone followed 24-48 hours later by 0.8 mg vaginal misoprostol. All included pregnancies were followed up for 8 weeks from mifepristone administration. Data were retrieved from national health registers. Multiple logistic regression provided adjusted odds ratios of surgical intervention with 95% confidence intervals. The discriminative ability of the risk factors in identifying surgical intervention was assessed by cross-validated area under the receiver operating characteristic curve.

RESULTS

Of 86,437 early medical abortions, 5320 (6.2%) underwent a surgical intervention within 8 weeks after induction. The proportion of surgical interventions increased from 3.5% in the 5th to 6th gestational week to 10.3% in week 9, odds ratio, 3.2 (95% confidence interval, 2.9-3.6). Compared with women aged 15-19 years, the risk of surgical intervention increased with increasing maternal age until the age of 30-34 years, odds ratio, 1.7 (95% confidence interval, 1.5-1.9), where after the risk decreased to an odds ratio for age group 40-49 of 1.2 (95% confidence interval, 1.0-1.4). Compared with nulliparous women, a history of only vaginal deliveries with spontaneous delivery of placenta implied an odds ratio of 1.1 (95% confidence interval, 1.0-1.2), women with a history of at least 1 cesarean delivery, an odds ratio of 1.5 (95% confidence interval, 1.3-1.6), and women having experienced a manual removal of placenta after a vaginal birth, an odds ratio of 2.0 (95% confidence interval, 1.7-2.4). Previous medically induced abortion decreased the risk of surgical intervention, odds ratio 0.84 (95% confidence interval, 0.78-0.91), whereas previous early (before 56 days of gestation) surgically induced abortion implied a 53% (95% confidence interval, 1.4-1.7) increased risk of surgical intervention. Previous surgical abortion after 55 days of gestation increased the risk by 17% (95% confidence interval, 1.1-1.3). The area under the receiver operating characteristic curve of the model including all quantified risk factors was 63% (95% confidence interval, 62-64%).

CONCLUSION

Gestational age, maternal age, previous deliveries, and history of medically and surgically induced abortions all had a significant influence on the risk of surgical intervention of early medical abortion. However, inclusion of all quantified risk factors still left most interventions unpredictable.

摘要

背景

通过非侵入性方式,终止妊娠的医疗方法增加了全球范围内获取堕胎的机会,并提高了不安全堕胎的安全性。然而,二次手术干预是药物流产最常见的并发症。

目的

我们旨在确定并量化在妊娠 9 周前接受药物诱导终止妊娠的女性中进行手术干预的风险因素。

研究设计

我们进行了一项全国性队列研究,包括在 2005 年至 2015 年期间 15 至 49 岁女性中妊娠 63 天内终止的所有妊娠。诱导方案为 200mg 米非司酮,24-48 小时后阴道给予 0.8mg 米索前列醇。所有纳入的妊娠均在米非司酮给药后 8 周内进行随访。数据从国家健康登记处检索。多因素逻辑回归提供了 95%置信区间的调整比值比。通过交叉验证的接收者操作特征曲线下面积评估了风险因素识别手术干预的能力。

结果

在 86437 例早期药物流产中,5320 例(6.2%)在诱导后 8 周内进行了手术干预。手术干预的比例从第 5 至 6 孕周的 3.5%增加到第 9 孕周的 10.3%,比值比为 3.2(95%置信区间,2.9-3.6)。与 15-19 岁的女性相比,随着产妇年龄的增加,手术干预的风险增加,直到 30-34 岁,比值比为 1.7(95%置信区间,1.5-1.9),此后,年龄组 40-49 岁的风险降低至 1.2(95%置信区间,1.0-1.4)。与未生育的女性相比,只有阴道分娩且胎盘自然娩出的病史意味着比值比为 1.1(95%置信区间,1.0-1.2),至少有 1 次剖宫产史的女性比值比为 1.5(95%置信区间,1.3-1.6),而经历过阴道分娩后手动胎盘剥离的女性比值比为 2.0(95%置信区间,1.7-2.4)。既往药物流产可降低手术干预的风险,比值比为 0.84(95%置信区间,0.78-0.91),而既往早期(妊娠 56 天前)手术流产则意味着手术干预的风险增加 53%(95%置信区间,1.4-1.7)。妊娠 55 天后的既往手术流产增加了 17%(95%置信区间,1.1-1.3)的风险。包括所有量化风险因素的模型的受试者工作特征曲线下面积为 63%(95%置信区间,62-64%)。

结论

妊娠周数、产妇年龄、既往分娩史和药物及手术流产史均对早期药物流产手术干预的风险有显著影响。然而,纳入所有量化风险因素仍然使大多数干预措施不可预测。

相似文献

1
Risk factors for surgical intervention of early medical abortion.早期药物流产行手术干预的危险因素。
Am J Obstet Gynecol. 2019 May;220(5):478.e1-478.e15. doi: 10.1016/j.ajog.2019.02.014. Epub 2019 Feb 11.
2
Risk of surgical evacuation and risk of major surgery following second-trimester medical abortion in Denmark: A nationwide cohort study.丹麦的一项全国性队列研究:妊娠中期药物流产后行手术清宫术的风险和行大手术的风险。
Contraception. 2020 Sep;102(3):201-206. doi: 10.1016/j.contraception.2020.04.017. Epub 2020 Jun 5.
3
Effect of previous live birth and prior route of delivery on the outcome of early medical abortion.既往活产史及既往分娩方式对早期药物流产结局的影响。
Obstet Gynecol. 2009 Mar;113(3):669-674. doi: 10.1097/AOG.0b013e31819638e6.
4
Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.低剂量米非司酮200毫克联合阴道用米索前列醇用于流产。
Contraception. 1999 Jan;59(1):1-6. doi: 10.1016/s0010-7824(98)00150-4.
5
Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.1998 - 2013年在挪威使用米非司酮和米索前列醇实施药物流产
Int J Epidemiol. 2017 Apr 1;46(2):643-651. doi: 10.1093/ije/dyw270.
6
Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases.妊娠64至91天的药物流产:483例连续病例回顾
Am J Obstet Gynecol. 2003 May;188(5):1315-9. doi: 10.1067/mob.2003.267.
7
Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.妊娠 50-63 天行门诊在家自行应用米索前列醇药物流产与妊娠<50 天行药物流产的比较。
Hum Reprod. 2010 May;25(5):1153-7. doi: 10.1093/humrep/deq037. Epub 2010 Feb 19.
8
Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.米非司酮与阴道用米索前列醇同日用于妊娠50至63天的流产。
Contraception. 2002 Oct;66(4):225-9. doi: 10.1016/s0010-7824(02)00358-x.
9
Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.米非司酮和米索前列醇早期药物流产后宫内排空的预测因素。
Contraception. 2016 Feb;93(2):119-25. doi: 10.1016/j.contraception.2015.08.010. Epub 2015 Aug 15.
10
Frequency and risk factors for repeat abortions after surgical compared with medical termination of pregnancy.与药物流产相比,手术流产后重复流产的发生率及危险因素。
Obstet Gynecol. 2009 Apr;113(4):845-852. doi: 10.1097/AOG.0b013e31819cae06.

引用本文的文献

1
Epidemiological trends in abortion and miscarriage between 1990 and 2019.1990年至2019年间堕胎与流产的流行病学趋势。
Reprod Health. 2025 Jun 5;22(1):97. doi: 10.1186/s12978-025-02049-3.
2
Development and validation of a risk assessment model for predicting the failure of early medical abortions: A clinical prediction model study based on a systematic review and meta-analysis.预测早期药物流产失败的风险评估模型的开发与验证:一项基于系统评价和荟萃分析的临床预测模型研究
PLoS One. 2024 Dec 20;19(12):e0315025. doi: 10.1371/journal.pone.0315025. eCollection 2024.
3
Clinical factors associated with subsequent surgical intervention in women undergoing early medical termination of viable or non-viable pregnancies.
接受早期人工终止可存活或不可存活妊娠的女性后续手术干预相关的临床因素。
Front Med (Lausanne). 2024 Apr 26;11:1188629. doi: 10.3389/fmed.2024.1188629. eCollection 2024.
4
Effectiveness and acceptability of "at home" versus "at hospital" early medical abortion - A lesson from the COVID-19 pandemic: A retrospective cohort study.“在家”与“在医院”早期药物流产的效果和可接受性——COVID-19 大流行带来的经验教训:一项回顾性队列研究。
Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:150-154. doi: 10.1016/j.ejogrb.2021.10.035. Epub 2021 Nov 3.
5
The implementation of routine procedural transvaginal sonography to decrease retained products of conception: a quality improvement initiative.实施常规经阴道超声检查以减少妊娠产物残留:一项质量改进举措。
BMC Womens Health. 2021 Oct 3;21(1):347. doi: 10.1186/s12905-021-01488-x.